Hot penny stocks... don't get burned
   

News for Repligen Cp (RGEN)

Markets Quote Depth/LII Options Charts News Profile Financials Insiders Filings Analyst Earnings Historical
Symbol: powered by
  quotemedia.com
News for Repligen Corp.  (RGEN) 
|
$ 4.25      0.64 (+17.73%) Volume: 289.27 k 4:00 PM EDT Oct 10, 2008
Wed, Sep 17, 2008
9:31 AM Repligen to Present at the 2008 UBS Global Life Sciences Conference Wednesday, September 24th, 1:00 p.m. EDT - PR Newswire
Tue, Sep 16, 2008
11:20 AM Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntington's Disease Model - PR Newswire
Thu, Sep 04, 2008
7:00 AM Repligen Receives Research Grants to Support Friedreich's Ataxia Development Program - PR Newswire
Thu, Aug 07, 2008
8:04 AM Repligen Reports First Quarter Fiscal Year 2009 Financial Results - PR Newswire
Thu, Jul 31, 2008
10:27 AM Repligen Announces Conference Call of First Quarter Fiscal Year 2009 Results - PR Newswire
Tue, Jul 08, 2008
11:31 AM Presentation of North America's First Certificate for BS 25999, the New Standard for Business Continuity - PR Newswire
Wed, Jul 02, 2008
9:00 AM 3SBio Inc. Announces Filing of Annual Report on Form 20-F and Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors - U.S. Equity News
Tue, Jul 01, 2008
10:02 AM Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors - PR Newswire
Mon, Jun 30, 2008
10:30 AM TapImmune Issued U.S. Patent Relating to Methods for Enhancing an Immune Response and Anika Therapeutics Announces Commercial Availability of MONOVISC(TM) in Europe - U.S. Equity News
8:02 AM Repligen Added to Russell 3000 Index - PR Newswire
Wed, Jun 18, 2008
7:16 AM Repligen Announces Share Repurchase Program - PR Newswire
Thu, Jun 12, 2008
7:00 AM Repligen Reports Fourth Quarter and Fiscal Year 2008 Financial Results - PR Newswire
7:00 AM Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder - PR Newswire
Fri, Jun 06, 2008
10:49 AM Repligen Announces Conference Call of Fourth Quarter and Fiscal Year 2008 Results - PR Newswire
Wed, Apr 16, 2008
1:15 PM Repligen Receives FDA Fast Track Designation for RG1068 for Pancreatic Imaging - PR Newswire
Tue, Apr 08, 2008
10:30 AM BellwetherReport.com Free Analyst Review for RGEN, AGEN, ASML and NTRI - Marketwire
7:01 AM Repligen Announces Settlement with Bristol-Myers Squibb in Orencia(R) Lawsuit - PR Newswire
Mon, Apr 07, 2008
7:19 PM Repligen Announces Conference Call to Update Orencia(R) Lawsuit - PR Newswire
Wed, Mar 26, 2008
8:00 AM Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging - PR Newswire
Thu, Feb 07, 2008
8:01 AM Repligen Reports Third Quarter Fiscal Year 2008 Financial Results - PR Newswire
Thu, Jan 31, 2008
8:05 AM Repligen Announces Conference Call of Third Quarter Fiscal Year 2008 Results - PR Newswire
Thu, Dec 13, 2007
3:10 PM Repligen Elects Earl Henry, M.D. to the Board of Directors - PR Newswire
Tue, Nov 20, 2007
9:11 AM Repligen to Present at Upcoming Healthcare Conferences Wednesday, November 28th and Wednesday, December 5th - PR Newswire
Thu, Nov 08, 2007
7:05 AM Repligen Reports Second Quarter Fiscal Year 2008 Financial Results - PR Newswire
7:02 AM Repligen Reports Positive Phase 2a Clinical Trial Results of RG2417 for Symptoms of Bipolar Disorder - PR Newswire
  Page 1 of 3   Next Page

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.   RT   Realtime,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMediaTerms of Use. 
   
Research Report
Hotstocked.com has a complete research report available for RGEN stock. Download RGEN report.
Research Report
Get the full report for FREE
Date:Sep 3, 2008
Price:Free
Pages:5
Document Type:Adobe Acrobat Reader
 Download RGEN report
  
Example preview: Research report for Repligen Cp (RGEN) Research report for Repligen Cp (RGEN) Research report for Repligen Cp (RGEN) Research report for Repligen Cp (RGEN)
   
   
   
   
   

Hot Green Energy Stock from China


From: OTC Journal
Added: 16 Sep, 2008

   

Add to Google
Add to My Yahoo!
rss
 
 
Home > Companies > Repligen Cp